(Q47289764)

13 January 2018

title

Breathlessness, night sweats, and weight loss on natalizumab (English)

1 reference

13 January 2018

1 reference

2

1 reference

13 January 2018

author name string

D Dahdaleh

series ordinal

1

1 reference

13 January 2018

O Malik

series ordinal

3

1 reference

13 January 2018

R S Nicholas

series ordinal

4

1 reference

13 January 2018

language of work or name

English

0 references

publication date

1 August 2012

1 reference

13 January 2018

published in

The Lancet

1 reference

13 January 2018

volume

380

1 reference

13 January 2018

issue

9843

1 reference

13 January 2018

page(s)

726-727

1 reference

13 January 2018

Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961401-9

7 January 2021

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961401-9

7 January 2021

Up-regulation of VCAM-1 and differential expansion of beta integrin-expressing T lymphocytes are associated with immunity to pulmonary Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961401-9

7 January 2021

Lymphocyte homing to bronchus-associated lymphoid tissue (BALT) is mediated by L-selectin/PNAd, alpha4beta1 integrin/VCAM-1, and LFA-1 adhesion pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961401-9

7 January 2021

10.1016/S0140-6736(12)61401-9

Identifiers

DOI

1 reference

13 January 2018

PubMed ID

22920745

1 reference

13 January 2018